Limited sampling strategy for estimation of mycophenolic acid and its glucuronide metabolites exposure in liver transplant recipients receiving enteric-coated mycophenolate sodium

Jiaqian LU,Xiaoxue LIU,Hao CHEN,Bing CHEN
DOI: https://doi.org/10.19577/j.1007-4406.2018.01.002
2018-01-01
Abstract:AIM To develop limited sampling strategy (LSS) for accurate prediction of the exposure for both mycophenolic acid (MPA) and its glucuronide metabolites in liver transplant recipients treated with entericcoated mycophenolate sodium (EC-MPS).METHODS Totally 35 liver transplant recipients were treated with EC-MPS,tacrolimus and prednisone.Plasma MPA,mycophenolic acid glucuronide(MPAG) and acyl mycophenolic acid glucuronide(AcMPAG) concentration (totally 49 cases) was measured before medication,0.5,1,2.5,2,2.5,3,4,8 and 12 h after medication using LC-MS/MS.Multiple linear regression analysis was used to determine 1-4 sampling estimation models.The selected models were validated by bootstrap procedure and Bland-Altman analysis.According to the sampling time of MPA selected models,the MPAG AUC and AcMPAG AUC models were established by multiple linear regression analysis.RESULTS The best equations obtained were for 3 and 4 time points:MPA AUC0→12 h =7.22 + 0.54 × ρ2 + 2.32 × ρ3 + 5.74 × ρ8 (R2 =0.79),AUC0→12 h =10.78 + 1.13 × ρ1.5 + 0.50 ×ρ2.5 + 1.37 ×ρ3 +3.32 ×ρ6 (R2 =0.84).In addition,corresponding MPAG and AcMPAG models had good prediction performance(R2 > 0.90).CONCLUSION Limited sampling strategy models using time points atρ2-ρ3-ρ8 orρ1.5-ρ2.5-ρ3-ρ6 provide the most reliable and accurate estimation of the AUC0→12 h of MPA and its glucuronide metabolites in Chinese liver transplant recipients receiving EC-MPS.
What problem does this paper attempt to address?